UK case control study of smoking and risk of amyotrophic lateral sclerosis
UK case control study of smoking and risk of amyotrophic lateral sclerosis
Introduction: Susceptibility to amyotrophic lateral sclerosis (ALS) is associated with smoking in some studies, but it is not clear which aspect of smoking behavior is related. Using detailed records of lifetime smoking we investigated the relationship between smoking and ALS in a UK population. Methods: In this retrospective case-control study, smoking status was collected using environmental questionnaires from people diagnosed with ALS between 2008 and 2013 and from age, sex and geographically matched controls. Categorical measures of smoking behavior were: smoking at the time of survey and smoking initiation; continuous measures were intensity (cigarettes per day), duration (years from starting to stopping or time of survey), cigarette pack years, and comprehensive smoking index (CSI), a measure of lifetime smoking. We used logistic regression to assess the risk of ALS with different combinations of smoking variables adjusted for age at survey, gender, level of education, smoking status and alcohol initiation, selecting the best model using the Akaike Information Criterion. Results: There were 388 records with full smoking history. The best-fitting model used CSI and smoking status at the time of survey. We found a weak association between current smoking and risk of ALS, OR 3.63 (95% CI 1.02–13.9) p value 0.05. Increase in CSI score did not increase risk of ALS: OR 0.81 (95% CI 0.58–1.11) p value 0.2.Conclusion: There is weak evidence of a positive effect of current smoking on the risk of ALS which does not show dose-dependence with higher levels of lifetime smoking and maybe a false positive result.
Amyotrophic lateral sclerosis, case control, smoking
222-227
Opie-Martin, Sarah
9030499e-3b21-45f6-bd50-43fdcc3d3059
Jones, Ashley
88875ff8-f810-4186-b815-a243a80bbc77
Iacoangeli, Alfredo
50f630e7-cf3a-4040-9294-ab567fce82d7
Al-Khleifat, Ahmad
36f3f499-11a5-4b0a-a617-23d44eab04e9
Oumar, Mohamed
40e11a74-749d-40c0-a71a-81103683b8cf
Shaw, Pamela J.
3d0a5c6f-9610-45be-a0bc-5b6888003028
Shaw, Chris E.
4c73e71a-70d1-4d3f-a08b-78d3e4a2d671
Morrison, Karen E.
f00890f0-2fde-4dbd-a73b-7422e1b0ede8
Wootton, Robyn E.
5d22cee6-3e7f-4165-9f25-d46a00b891d4
Davey-Smith, George
0de6af8f-976a-477d-a944-a98d0c8c1ebb
Pearce, Neil
99caea3a-6e0a-42c4-a85a-2d5a5b34bced
Al-Chalabi, Ammar
8ac40bc3-a3c0-47ad-afa7-37e08f7aab6f
May 2020
Opie-Martin, Sarah
9030499e-3b21-45f6-bd50-43fdcc3d3059
Jones, Ashley
88875ff8-f810-4186-b815-a243a80bbc77
Iacoangeli, Alfredo
50f630e7-cf3a-4040-9294-ab567fce82d7
Al-Khleifat, Ahmad
36f3f499-11a5-4b0a-a617-23d44eab04e9
Oumar, Mohamed
40e11a74-749d-40c0-a71a-81103683b8cf
Shaw, Pamela J.
3d0a5c6f-9610-45be-a0bc-5b6888003028
Shaw, Chris E.
4c73e71a-70d1-4d3f-a08b-78d3e4a2d671
Morrison, Karen E.
f00890f0-2fde-4dbd-a73b-7422e1b0ede8
Wootton, Robyn E.
5d22cee6-3e7f-4165-9f25-d46a00b891d4
Davey-Smith, George
0de6af8f-976a-477d-a944-a98d0c8c1ebb
Pearce, Neil
99caea3a-6e0a-42c4-a85a-2d5a5b34bced
Al-Chalabi, Ammar
8ac40bc3-a3c0-47ad-afa7-37e08f7aab6f
Opie-Martin, Sarah, Jones, Ashley, Iacoangeli, Alfredo, Al-Khleifat, Ahmad, Oumar, Mohamed, Shaw, Pamela J., Shaw, Chris E., Morrison, Karen E., Wootton, Robyn E., Davey-Smith, George, Pearce, Neil and Al-Chalabi, Ammar
(2020)
UK case control study of smoking and risk of amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21 (3-4), .
(doi:10.1080/21678421.2019.1706580).
Abstract
Introduction: Susceptibility to amyotrophic lateral sclerosis (ALS) is associated with smoking in some studies, but it is not clear which aspect of smoking behavior is related. Using detailed records of lifetime smoking we investigated the relationship between smoking and ALS in a UK population. Methods: In this retrospective case-control study, smoking status was collected using environmental questionnaires from people diagnosed with ALS between 2008 and 2013 and from age, sex and geographically matched controls. Categorical measures of smoking behavior were: smoking at the time of survey and smoking initiation; continuous measures were intensity (cigarettes per day), duration (years from starting to stopping or time of survey), cigarette pack years, and comprehensive smoking index (CSI), a measure of lifetime smoking. We used logistic regression to assess the risk of ALS with different combinations of smoking variables adjusted for age at survey, gender, level of education, smoking status and alcohol initiation, selecting the best model using the Akaike Information Criterion. Results: There were 388 records with full smoking history. The best-fitting model used CSI and smoking status at the time of survey. We found a weak association between current smoking and risk of ALS, OR 3.63 (95% CI 1.02–13.9) p value 0.05. Increase in CSI score did not increase risk of ALS: OR 0.81 (95% CI 0.58–1.11) p value 0.2.Conclusion: There is weak evidence of a positive effect of current smoking on the risk of ALS which does not show dose-dependence with higher levels of lifetime smoking and maybe a false positive result.
Text
UK case control study of smoking and risk of amyotrophic lateral sclerosis
- Version of Record
More information
Accepted/In Press date: 30 November 2019
e-pub ahead of print date: 17 April 2020
Published date: May 2020
Additional Information:
Funding Information:
This project was funded through the Motor Neurone Disease Association. Data used in this research were entirely obtained from the UK MND Collections?epidemiology data for MND Research, funded by the MND Association and the Wellcome Trust. The project is supported through the following funding organizations under the egis of JPND?www.jpnd.eu (United Kingdom, Medical Research Council [MR/L501529/1; MR/R024804/1] and Economic and Social Research Council [ES/L008238/1). This study represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Center at South London and Maudsley NHS Foundation Trust and King?s College London. The work leading up to this publication was funded by the European Community?s Health Seventh Framework Program (FP7/2007?2013; grant agreement number [259867]) and Horizon 2020 Program (H2020-PHC-2014-two-stage; grant agreement number [633413]). We would like to thank people with MND and their families for their participation in this project. This is in part an EU Joint Program?Neurodegenerative Disease Research (JPND) project.
Publisher Copyright:
© 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Keywords:
Amyotrophic lateral sclerosis, case control, smoking
Identifiers
Local EPrints ID: 440703
URI: http://eprints.soton.ac.uk/id/eprint/440703
ISSN: 2167-8421
PURE UUID: 3f36efa7-0c5e-4186-b172-cacf15a22def
Catalogue record
Date deposited: 13 May 2020 17:06
Last modified: 16 Mar 2024 07:45
Export record
Altmetrics
Contributors
Author:
Sarah Opie-Martin
Author:
Ashley Jones
Author:
Alfredo Iacoangeli
Author:
Ahmad Al-Khleifat
Author:
Mohamed Oumar
Author:
Pamela J. Shaw
Author:
Chris E. Shaw
Author:
Karen E. Morrison
Author:
Robyn E. Wootton
Author:
George Davey-Smith
Author:
Neil Pearce
Author:
Ammar Al-Chalabi
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics